Regulatory and conformity documents (CE/IFU) should be requested from the manufacturer/distributor to confirm market status in your jurisdiction.
Regulatory and conformity documents (CE/IFU) should be requested from the manufacturer/distributor to confirm market status in your jurisdiction.
Injectable Skinbooster (Hyaluronic Acid)
Description
Nexfill PRO 80 is an advanced injectable skinbooster formulated for intensive dermal hydration and skin renewal. Marketed with an ultra-high hyaluronic acid (HA) load of 80 mg per 2.5 mL syringe, it is intended for professional intradermal/subdermal micro-injection to improve skin texture, hydration, elasticity and radiance. Supplied as a prefilled 2.5 mL syringe for administration by trained aesthetic practitioners.
Bnefits
Ultra-high HA content (80 mg per 2.5 mL syringe) for deep dermal hydration and skin quality improvement.
Designed to improve skin texture, tone, elasticity and radiance.
Ready-to-use prefilled syringe format for microinjection/mesotherapy techniques.
Positioned as an alternative to other high-concentration skinboosters for face, neck, décolletage and hands.
Indications
Dermal rehydration and improvement of skin quality for face, neck, décolletage and hands.
Adjunctive treatment for fine lines, superficial skin laxity and dull/dehydrated skin where skinbooster therapy is appropriate.
Intended for use by trained aesthetic clinicians using intradermal or subdermal microinjection techniques.
Composition
Hyaluronic acid — 80 mg per 2.5 mL syringe (manufacturer/retailer marketing).
Reported balanced mix of low- and high-molecular-weight HA (marketing claims; exact MW distribution and crosslinking method to be confirmed by manufacturer).
Sterile aqueous vehicle and standard excipients for injectable skinbooster formulations (full INCI/IFU to be obtained from manufacturer/distributor).
For professional use only — to be administered by trained medical/aesthetic practitioners.
Inject intradermally/subdermally using micro-droplet / mesotherapy techniques according to clinician judgement and manufacturer guidance.
Typical treatment courses vary by clinic; some protocols use 1–3 sessions spaced 2–4 weeks apart followed by maintenance treatments.
Follow aseptic technique and local aftercare instructions (sunscreen, avoid intense heat/exercise for 24–48 hours).
Contraindications
Active infection or inflammation at the intended injection site.
Known hypersensitivity to any component of the product.
Patients with bleeding disorders or on anticoagulant therapy without specialist advice.
Pregnancy and breastfeeding — use only after clinician risk–benefit assessment.
Adverse Effects
Common (usually transient): injection-site redness, swelling, bruising, pain/tenderness, small lumps or nodularity.
Uncommon/serious: infection, persistent nodules, hypersensitivity reactions; rare risk of vascular compromise that requires immediate management.
Follow standard injectable-product precautions and emergency protocols.
Storage Conditions
Store in original packaging in a cool, dry place away from direct sunlight.
Avoid freezing and excessive heat; follow any specific temperature range printed on product IFU/box.
Keep out of reach of children.
Duration
Duration varies by patient and treated area; maintenance treatments commonly recommended (typical clinic-reported intervals often 4\u20139 months depending on protocol and patient factors).
Onset
Immediate improvement in skin hydration and glow after treatment; progressive enhancement in texture and firmness over days to weeks.
